Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 272 participants.
Also called NCT07552194
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 272 participants
- Registry
-
NCT07552194
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07552194. Randomized; double masking; primary purpose treatment. Start 2026-06-02 (anticipated); primary completion 2027-12-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)
- Acronym
- ROBUST
- Condition
- Coronary Bifurcation Lesion
- Condition
- Coronary Stenting
- Condition
- Drug Eluting Balloon
- Intervention (Device)
- Balloon Angioplasty with or without drug administration
- Lead sponsor
- Avtandil M. Babunashvili
- Collaborator
- I.M. Sechenov First Moscow State Medical University
Record details
- Record id
cardio:ct-nct07552194- Content hash
cf0795b8fdf99dcf83e9af01db2aab69be41b34127a08241e25597694de1c8be